Delivery Order SPE2DE21D7010-SPE2D625F5K3P
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products and technologies, was awarded a delivery order valued at $8,533.00 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 14, 2025. This fixed-price delivery order with economic price adjustment mechanism does not utilize any set-aside designation, indicating the contract was awarded through open market competition. The contract is scheduled for completion by August 15, 2025, and...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $1,681.90 by the Defense Logistics Agency (DLA) Medical Supply Chain on July 24, 2025. This fixed-price contract with economic price adjustment mechanisms is set to be completed by July 25, 2025. The award represents an open market procurement with no set-aside designation, consistent with Nuvasive's established competitive success in federal healthcare...
- Nuvasive, Inc., a leading medical device manufacturer specializing in spinal surgery products and implants, was awarded a delivery order valued at $1,956.60 by the Defense Logistics Agency (DLA) Medical Supply Chain on August 21, 2025. The contract, which is not associated with any set-aside designation, carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by September 22, 2025. The place of performance is located in San Diego, California,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 on May 28, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as delivery order 4568393753 for the SMALL INTERLOCK II product, is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of June 17, 2025. This award was made without any set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, was awarded a delivery order valued at $5,189.76 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 2, 2025. The contract, designated as "SMALL INTERLOCK II," represents a fixed-price delivery order with economic price adjustment mechanisms and carries an ultimate completion date of September 22, 2025. The award was made without any set-aside designation,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, received a $3,317.80 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 8, 2025, with an ultimate completion date of September 26, 2025. This contract award carries no set-aside designation and includes economic price adjustment provisions. The award supports the federal government's medical supply chain operations, which fall under the...
- Nuvasive, Inc., a San Diego-based medical device manufacturer specializing in spinal surgery products, received a $1,956.60 fixed-price delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on September 11, 2025, with an ultimate completion date of October 3, 2025. This contract, awarded without set-aside designation, demonstrates Nuvasive's continued role as a key supplier of advanced spinal medical technologies to federal healthcare agencies. The delivery order utilizes a...
- Nuvasive, Inc. was awarded a $21,488.67 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense-focused federal agency, on April 29, 2025. The delivery order, which is not set-aside designated, requires completion by May 19, 2025, and will be performed in San Diego, California. As a leading medical device manufacturer specializing in spinal surgery products, Nuvasive supplies advanced spinal implants, fusion devices,...
- Nuvasive, Inc. has been awarded a $37,861.56 delivery order by the Defense Logistics Agency's Medical Supply Chain division, a defense-focused federal agency supporting Department of Defense and Veterans Affairs healthcare operations. This fixed-price contract with economic price adjustment mechanisms is scheduled for completion by September 18, 2025, and involves the delivery of specialized spinal medical technologies and surgical equipment to support military and veteran healthcare...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, was awarded a $46,066.90 fixed-price delivery order (Contract No. 4568371925, RELINE-ONE) by the Defense Logistics Agency (DLA) Medical Supply Chain on May 28, 2025. The delivery order, which utilizes an economic price adjustment mechanism, is scheduled for ultimate completion on May 29, 2025, and will be performed in San Diego, California. This award was made without a set-aside designation,...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D625F5K3PDelivery Order
Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, was awarded a $16,854 delivery order contract by the Defense Logistics Agency (DLA) Medical Supply Chain on April 30, 2025. This fixed-price contract with economic price adjustment provisions is classified as a delivery order with no set-aside designation, reflecting Nuvasive's competitive success in open market procurements. The contract is scheduled for completion by May 1, 2025, and will be performed at the company's San Diego, California facility. Nuvasive operates as a parent company providing advanced spinal medical technologies, implants, instruments, and biologics to federal healthcare agencies, including the Department of Defense, Department of Veterans Affairs, and Defense Health Agency. This delivery order supports the DLA Medical Supply Chain's mission to provision specialized medical technologies to military and veteran healthcare facilities. Nuvasive's contract portfolio demonstrates its established role as a key supplier of spinal medical devices and surgical solutions, complemented by its participation in larger indefinite delivery vehicles, including an $8 million Blanket Purchase Agreement with the Defense Health Agency effective through March 2027. The parent company, Transplant Technology Inc., which operates through its Bone Bank Allografts division, maintains substantial federal contracting relationships with multiple military health system entities, positioning Nuvasive as a critical supplier of orthopedic and spinal surgical technologies within the federal healthcare procurement ecosystem.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.9k | 4/30/25 |